These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 22454288)
21. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison. Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076 [TBL] [Abstract][Full Text] [Related]
22. Effect of fibre additions to flatbread flour mixes on glucose kinetics: a randomised controlled trial. Boers HM; van Dijk TH; Hiemstra H; Hoogenraad AR; Mela DJ; Peters HPF; Vonk RJ; Priebe MG Br J Nutr; 2017 Nov; 118(10):777-787. PubMed ID: 29110741 [TBL] [Abstract][Full Text] [Related]
23. Leucine kinetics from [2H3]- and [13C]leucine infused simultaneously by gut and vein. Hoerr RA; Matthews DE; Bier DM; Young VR Am J Physiol; 1991 Jan; 260(1 Pt 1):E111-7. PubMed ID: 1987785 [TBL] [Abstract][Full Text] [Related]
24. Accurate Measurement of Postprandial Glucose Turnover: Why Is It Difficult and How Can It Be Done (Relatively) Simply? Rizza RA; Toffolo G; Cobelli C Diabetes; 2016 May; 65(5):1133-45. PubMed ID: 27208180 [TBL] [Abstract][Full Text] [Related]
25. Methods for assessment of the rate of onset and offset of insulin action during nonsteady state in humans. Butler PC; Caumo A; Zerman A; O'Brien PC; Cobelli C; Rizza RA Am J Physiol; 1993 Apr; 264(4 Pt 1):E548-60. PubMed ID: 8476033 [TBL] [Abstract][Full Text] [Related]
26. Demonstration of glycated insulin in human diabetic plasma and decreased biological activity assessed by euglycemic-hyperinsulinemic clamp technique in humans. Hunter SJ; Boyd AC; O'Harte FP; McKillop AM; Wiggam MI; Mooney MH; McCluskey JT; Lindsay JR; Ennis CN; Gamble R; Sheridan B; Barnett CR; McNulty H; Bell PM; Flatt PR Diabetes; 2003 Feb; 52(2):492-8. PubMed ID: 12540626 [TBL] [Abstract][Full Text] [Related]
27. Sotagliflozin Decreases Postprandial Glucose and Insulin Concentrations by Delaying Intestinal Glucose Absorption. Powell DR; Zambrowicz B; Morrow L; Beysen C; Hompesch M; Turner S; Hellerstein M; Banks P; Strumph P; Lapuerta P J Clin Endocrinol Metab; 2020 Apr; 105(4):e1235-49. PubMed ID: 31837264 [TBL] [Abstract][Full Text] [Related]
28. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial. Barnett AH; Burger J; Johns D; Brodows R; Kendall DM; Roberts A; Trautmann ME Clin Ther; 2007 Nov; 29(11):2333-48. PubMed ID: 18158075 [TBL] [Abstract][Full Text] [Related]
29. Hepatic and extrahepatic insulin action in humans: measurement in the absence of non-steady-state error. Katz H; Butler P; Homan M; Zerman A; Caumo A; Cobelli C; Rizza R Am J Physiol; 1993 Apr; 264(4 Pt 1):E561-6. PubMed ID: 8476034 [TBL] [Abstract][Full Text] [Related]
30. Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes. Hanefeld M; Koehler C; Hoffmann C; Wilhelm K; Kamke W; Gerstein H Diabet Med; 2010 Feb; 27(2):175-80. PubMed ID: 20546261 [TBL] [Abstract][Full Text] [Related]
31. Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM. Dinneen S; Alzaid A; Turk D; Rizza R Diabetologia; 1995 Mar; 38(3):337-43. PubMed ID: 7758881 [TBL] [Abstract][Full Text] [Related]
32. Very immature infants (< or = 30 Wk) respond to glucose infusion with incomplete suppression of glucose production. Sunehag A; Gustafsson J; Ewald U Pediatr Res; 1994 Oct; 36(4):550-5. PubMed ID: 7816531 [TBL] [Abstract][Full Text] [Related]
33. The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients. Poulsen MK; Henriksen JE; Hother-Nielsen O; Beck-Nielsen H Diabetes Care; 2003 Dec; 26(12):3273-9. PubMed ID: 14633813 [TBL] [Abstract][Full Text] [Related]
34. Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism. Basu A; Dalla Man C; Basu R; Toffolo G; Cobelli C; Rizza RA Diabetes Care; 2009 May; 32(5):866-72. PubMed ID: 19196896 [TBL] [Abstract][Full Text] [Related]
35. Peripheral and hepatic insulin sensitivity in subjects with impaired glucose tolerance. Berrish TS; Hetherington CS; Alberti KG; Walker M Diabetologia; 1995 Jun; 38(6):699-704. PubMed ID: 7672492 [TBL] [Abstract][Full Text] [Related]
36. Incomplete suppression of hepatic glucose production in non-insulin dependent diabetes mellitus measured with [6,6-2H2]glucose enriched glucose infusion during hyperinsulinaemic euglycaemic clamps. Powrie JK; Smith GD; Hennessy TR; Shojaee-Moradie F; Kelly JM; Sönksen PH; Jones RH Eur J Clin Invest; 1992 Apr; 22(4):244-53. PubMed ID: 1499640 [TBL] [Abstract][Full Text] [Related]